Puma Biotechnology, Inc.
US ˙ NasdaqGS ˙ US74587V1070

Introduction

This page provides a comprehensive analysis of the known insider trading history of Alan H Auerbach. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Alan H Auerbach has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:PBYI / Puma Biotechnology, Inc. President and CEO, Director, 10% Owner 7,180,901
US:RDUS / Radius Recycling, Inc. Director 27,500
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Alan H Auerbach. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PBYI / Puma Biotechnology, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PBYI / Puma Biotechnology, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PBYI / Puma Biotechnology, Inc. Insider Trades
Insider Sales PBYI / Puma Biotechnology, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PBYI / Puma Biotechnology, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2023-01-03 PBYI AUERBACH ALAN H 27,241 4.1779 27,241 4.1779 113,810 79 2.2100 -53,607 -47.10
2022-12-02 PBYI AUERBACH ALAN H 1,251 4.4978 1,251 4.4978 5,627
2022-11-02 PBYI AUERBACH ALAN H 1,242 2.2500 1,242 2.2500 2,794
2022-10-03 PBYI AUERBACH ALAN H 1,260 2.3354 1,260 2.3354 2,943
2022-09-02 PBYI AUERBACH ALAN H 1,254 2.5896 1,254 2.5896 3,247
2022-08-02 PBYI AUERBACH ALAN H 1,247 2.8900 1,247 2.8900 3,604
2022-07-05 PBYI AUERBACH ALAN H 26,140 2.6315 26,140 2.6315 68,787
2022-06-02 PBYI AUERBACH ALAN H 1,200 1.9441 1,200 1.9441 2,333
2022-05-03 PBYI AUERBACH ALAN H 1,263 2.3201 1,263 2.3201 2,930
2022-04-04 PBYI AUERBACH ALAN H 1,198 3.0780 1,198 3.0780 3,687
2022-03-02 PBYI AUERBACH ALAN H 1,294 2.2561 1,294 2.2561 2,919
2022-02-02 PBYI AUERBACH ALAN H 1,316 2.4610 1,316 2.4610 3,239
2022-01-03 PBYI AUERBACH ALAN H 22,875 3.1879 22,875 3.1879 72,923
2021-12-02 PBYI AUERBACH ALAN H 1,837 2.9000 1,837 2.9000 5,327
2021-11-02 PBYI AUERBACH ALAN H 1,795 5.6334 1,795 5.6334 10,112
2021-10-04 PBYI AUERBACH ALAN H 1,858 6.1535 1,858 6.1535 11,433
2021-09-02 PBYI AUERBACH ALAN H 1,764 7.5980 1,764 7.5980 13,403
2021-08-02 PBYI AUERBACH ALAN H 1,764 7.5316 1,764 7.5316 13,286
2021-07-02 PBYI AUERBACH ALAN H 5,332 8.8374 5,332 8.8374 47,121
2021-06-02 PBYI AUERBACH ALAN H 1,757 10.7441 1,757 10.7441 18,877
2021-05-03 PBYI AUERBACH ALAN H 1,758 9.0140 1,758 9.0140 15,847
2021-04-05 PBYI AUERBACH ALAN H 1,584 9.8029 1,584 9.8029 15,528
2021-03-02 PBYI AUERBACH ALAN H 1,238 10.1418 1,238 10.1418 12,556
2021-02-02 PBYI AUERBACH ALAN H 1,222 12.2183 1,222 12.2183 14,931
2021-01-04 PBYI AUERBACH ALAN H 18,235 10.2210 18,235 10.2210 186,380
2020-12-02 PBYI AUERBACH ALAN H 355 11.6560 355 11.6560 4,138
2020-11-02 PBYI AUERBACH ALAN H 371 7.8151 371 7.8151 2,899
2020-10-02 PBYI AUERBACH ALAN H 350 10.1280 350 10.1280 3,545
2020-09-02 PBYI AUERBACH ALAN H 347 9.7791 347 9.7791 3,393
2020-08-03 PBYI AUERBACH ALAN H 330 10.7900 330 10.7900 3,561
2020-07-02 PBYI AUERBACH ALAN H 2,607 10.6646 2,607 10.6646 27,803
2020-06-02 PBYI AUERBACH ALAN H 100 10.7010 100 10.7010 1,070
2020-06-02 PBYI AUERBACH ALAN H 242 10.7100 242 10.7100 2,592
2020-05-04 PBYI AUERBACH ALAN H 339 9.7012 339 9.7012 3,289
2020-04-02 PBYI AUERBACH ALAN H 347 7.3850 347 7.3850 2,563
2020-03-02 PBYI AUERBACH ALAN H 372 10.0151 372 10.0151 3,726
2020-02-03 PBYI AUERBACH ALAN H 331 8.0145 331 8.0145 2,653
2020-01-02 PBYI AUERBACH ALAN H 43 8.3201 43 8.3201 358
2020-01-02 PBYI AUERBACH ALAN H 5,973 8.3900 5,973 8.3900 50,113
2019-12-02 PBYI AUERBACH ALAN H 455 10.3289 455 10.3289 4,700
2019-11-04 PBYI AUERBACH ALAN H 378 7.4000 378 7.4000 2,797
2019-11-04 PBYI AUERBACH ALAN H 100 7.4001 100 7.4001 740
2019-10-02 PBYI AUERBACH ALAN H 504 9.9745 504 9.9745 5,027
2019-09-04 PBYI AUERBACH ALAN H 524 10.1400 524 10.1400 5,313
2019-08-02 PBYI AUERBACH ALAN H 516 9.0300 516 9.0300 4,659
2019-08-02 PBYI AUERBACH ALAN H 1 9.0100 1 9.0100 9
2019-07-02 PBYI AUERBACH ALAN H 495 12.7800 495 12.7800 6,326
2019-06-03 PBYI AUERBACH ALAN H 483 15.1800 483 15.1800 7,332
2019-05-02 PBYI AUERBACH ALAN H 477 32.3801 477 32.3801 15,445
2019-04-02 PBYI AUERBACH ALAN H 491 35.7904 491 35.7904 17,573
2019-03-04 PBYI AUERBACH ALAN H 496 38.6200 496 38.6200 19,156
2019-02-04 PBYI AUERBACH ALAN H 345 27.8000 345 27.8000 9,591
2019-01-03 PBYI AUERBACH ALAN H 4,424 20.6700 4,424 20.6700 91,444

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PBYI / Puma Biotechnology, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Alan H Auerbach as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-10 2025-07-09 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -21,580 7,180,901 -0.30 3.54 -76,285 25,384,485
2025-07-10 2025-07-08 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -25,592 7,202,481 -0.35 3.53 -90,417 25,446,365
2025-02-11 2025-02-07 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 198,399 7,228,073 2.82
2025-01-03 2025-01-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -33,841 7,029,674 -0.48 3.15 -106,657 22,155,424
2024-07-18 2024-07-17 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -21,920 7,063,515 -0.31 3.70 -81,128 26,142,775
2024-07-02 2024-07-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -18,885 7,085,435 -0.27 3.27 -61,726 23,158,744
2024-03-19 2024-03-15 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 6,577 7,104,320 0.09
2024-02-14 2024-02-12 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 160,796 7,097,743 2.32
2024-01-05 2024-01-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -41,396 6,936,947 -0.59 4.49 -185,698 31,118,451
2023-07-06 2023-07-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale X -60,698 6,978,343 -0.86 3.31 -200,983 23,106,689
2023-02-14 2023-02-10 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 186,403 7,039,041 2.72
2023-01-05 2023-01-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -27,241 6,852,638 -0.40 4.18 -113,810 28,629,636
2022-12-12 2022-12-12 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 568,181 6,879,879 9.00 4.40 2,499,996 30,271,468
2022-12-06 2022-12-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,251 6,311,698 -0.02 4.50 -5,627 28,388,755
2022-11-04 2022-11-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,242 6,312,949 -0.02 2.25 -2,794 14,204,135
2022-10-05 2022-10-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,260 6,314,191 -0.02 2.34 -2,943 14,746,162
2022-09-07 2022-09-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,254 6,315,451 -0.02 2.59 -3,247 16,354,492
2022-08-04 2022-08-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,247 6,316,705 -0.02 2.89 -3,604 18,255,277
2022-07-07 2022-07-05 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -26,140 6,317,952 -0.41 2.63 -68,787 16,625,691
2022-06-06 2022-06-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,200 6,344,092 -0.02 1.94 -2,333 12,333,549
2022-05-04 2022-05-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,263 6,345,292 -0.02 2.32 -2,930 14,721,712
2022-04-05 2022-04-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,198 6,346,555 -0.02 3.08 -3,687 19,534,696
2022-03-14 2022-03-10 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 1,792,114 6,347,753 39.34 2.79 4,999,998 17,710,231
2022-03-14 2022-03-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 241,176 241,176
2022-03-14 2022-03-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
A - Award 168,824 4,555,639 3.85
2022-03-04 2022-03-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,294 4,386,815 -0.03 2.26 -2,919 9,897,093
2022-02-03 2022-02-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,316 4,388,109 -0.03 2.46 -3,239 10,799,136
2022-01-05 2022-01-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -22,875 4,389,425 -0.52 3.19 -72,923 13,993,048
2021-12-06 2021-12-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,837 4,412,300 -0.04 2.90 -5,327 12,795,670
2021-11-03 2021-11-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,795 4,414,137 -0.04 5.63 -10,112 24,866,599
2021-10-06 2021-10-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
Common Stock
S - Sale -1,858 4,415,932 -0.04 6.15 -11,433 27,173,438
2021-09-03 2021-09-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1,764 4,417,790 -0.04 7.60 -13,403 33,566,368
2021-08-03 2021-08-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1,764 4,419,554 -0.04 7.53 -13,286 33,286,313
2021-07-06 2021-07-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -5,332 4,421,318 -0.12 8.84 -47,121 39,072,956
2021-06-04 2021-06-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1,757 4,426,650 -0.04 10.74 -18,877 47,560,370
2021-05-05 2021-05-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1,758 4,428,407 -0.04 9.01 -15,847 39,917,661
2021-04-06 2021-04-05 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1,584 4,430,165 -0.04 9.80 -15,528 43,428,464
2021-03-04 2021-03-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1,238 4,431,749 -0.03 10.14 -12,556 44,945,912
2021-02-19 2021-02-17 4 PBYI PUMA BIOTECHNOLOGY, INC.
STOCK OPTION (RIGHT TO BUY)
A - Award 210,944 210,944
2021-02-19 2021-02-17 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
A - Award 149,951 4,432,987 3.50
2021-02-04 2021-02-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1,222 4,283,036 -0.03 12.22 -14,931 52,331,419
2021-01-06 2021-01-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -18,235 4,284,258 -0.42 10.22 -186,380 43,789,401
2020-12-04 2020-12-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -355 4,302,493 -0.01 11.66 -4,138 50,149,858
2020-11-03 2020-11-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -371 4,302,848 -0.01 7.82 -2,899 33,627,187
2020-10-05 2020-10-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -350 4,303,219 -0.01 10.13 -3,545 43,583,002
2020-09-03 2020-09-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -347 4,303,569 -0.01 9.78 -3,393 42,085,032
2020-08-05 2020-08-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -330 4,303,916 -0.01 10.79 -3,561 46,439,254
2020-07-06 2020-07-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -2,607 4,304,246 -0.06 10.66 -27,803 45,903,062
2020-06-04 2020-06-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -242 4,306,853 -0.01 10.71 -2,592 46,126,396
2020-06-04 2020-06-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -100 4,307,095 0.00 10.70 -1,070 46,090,224
2020-05-06 2020-05-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -339 4,307,195 -0.01 9.70 -3,289 41,784,960
2020-04-03 2020-04-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -347 4,307,534 -0.01 7.38 -2,563 31,811,139
2020-03-03 2020-03-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -372 4,307,881 -0.01 10.02 -3,726 43,143,859
2020-02-13 2020-02-11 4 PBYI PUMA BIOTECHNOLOGY, INC.
STOCK OPTION (RIGHT TO BUY)
A - Award 161,649 161,649
2020-02-13 2020-02-11 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
A - Award 127,553 4,308,253 3.05
2020-02-04 2020-02-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -331 4,180,700 -0.01 8.01 -2,653 33,506,220
2020-01-03 2020-01-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -5,973 4,181,031 -0.14 8.39 -50,113 35,078,850
2020-01-03 2020-01-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -43 4,187,004 0.00 8.32 -358 34,836,292
2019-12-03 2019-12-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -455 4,187,047 -0.01 10.33 -4,700 43,247,590
2019-11-05 2019-11-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -100 4,187,502 0.00 7.40 -740 30,987,934
2019-11-05 2019-11-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -378 4,187,602 -0.01 7.40 -2,797 30,988,255
2019-10-03 2019-10-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -504 4,187,980 -0.01 9.97 -5,027 41,773,007
2019-09-06 2019-09-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -524 4,188,484 -0.01 10.14 -5,313 42,471,228
2019-08-05 2019-08-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -1 4,189,008 0.00 9.01 -9 37,742,962
2019-08-05 2019-08-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -516 4,189,009 -0.01 9.03 -4,659 37,826,751
2019-07-24 2019-07-22 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale X -12,715 4,189,525 -0.30 9.98 -126,846 41,795,120
2019-07-03 2019-07-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -495 4,202,240 -0.01 12.78 -6,326 53,704,627
2019-06-05 2019-06-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -483 4,202,735 -0.01 15.18 -7,332 63,797,517
2019-05-06 2019-05-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -477 4,203,218 -0.01 32.38 -15,445 136,100,619
2019-04-03 2019-04-02 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -491 4,203,695 -0.01 35.79 -17,573 150,451,926
2019-03-22 2019-03-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -496 4,204,186 -0.01 38.62 -19,156 162,365,663
2019-02-08 2019-02-06 4 PBYI PUMA BIOTECHNOLOGY, INC.
STOCK OPTION (RIGHT TO BUY)
A - Award 62,634 62,634
2019-02-08 2019-02-06 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
A - Award 39,215 4,204,682 0.94
2019-02-06 2019-02-04 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -345 4,165,467 -0.01 27.80 -9,591 115,799,983
2019-01-24 2019-01-22 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale X -8,825 4,165,812 -0.21 24.74 -218,334 103,063,855
2019-01-04 2019-01-03 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale -4,424 4,174,637 -0.11 20.67 -91,444 86,289,747
2018-07-24 2018-07-20 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale X -12,520 4,179,061 -0.30 52.00 -651,020 217,304,486
2018-02-13 2018-02-11 4 PBYI PUMA BIOTECHNOLOGY, INC.
STOCK OPTION (RIGHT TO BUY)
A - Award 56,940 56,940
2018-02-13 2018-02-11 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
A - Award 35,650 4,191,581 0.86
2018-01-24 2018-01-22 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale X -10,692 4,155,931 -0.26 92.75 -991,683 385,462,600
2017-07-24 2017-07-20 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale X -4,000 4,166,623 -0.10 95.60 -382,400 398,329,159
2017-07-24 2017-07-20 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale X -9,175 4,170,623 -0.22 94.34 -865,605 393,472,839
2017-02-22 2017-02-17 4 RDUS Radius Health, Inc.
Stock Option (Right to Buy)
A - Award 27,500 27,500
2017-02-21 2017-02-16 4 PBYI PUMA BIOTECHNOLOGY, INC.
STOCK OPTION (RIGHT TO BUY)
A - Award 70,000 70,000
2017-01-24 2017-01-20 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
S - Sale X -10,202 4,179,798 -0.24 33.24 -339,064 138,916,005
2016-10-14 2016-10-14 4 PBYI PUMA BIOTECHNOLOGY, INC.
COMMON STOCK
A - Award 150,000 4,190,000 3.71
2016-06-02 2016-05-24 4 RDUS Radius Health, Inc.
Stock Option (Right to Buy)
A - Award 27,500 27,500
2016-05-27 2016-05-25 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 66,667 66,667
2016-02-12 2016-02-10 4 RDUS Radius Health, Inc.
Stock Option (Right to Buy)
A - Award 27,500 27,500
2015-10-09 2015-10-07 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 150,000 150,000
2015-05-26 2015-05-07 4 RDUS Radius Health, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2014-12-19 2014-12-17 4 RDUS Radius Health, Inc.
Stock Option (Right to Buy)
A - Award 30,000 30,000
2014-12-17 2014-12-15 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy
A - Award 150,000 150,000
2013-10-29 2013-10-25 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 150,000 150,000
2012-12-18 2012-12-17 4 PBYI PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 150,000 150,000
2012-10-31 2012-10-24 4 PBYI PUMA BIOTECHNOLOGY, INC.
Warrant to Purchase Common Stock
A - Award 2,116,250 2,116,250
2012-02-14 2012-02-13 4 NONE PUMA BIOTECHNOLOGY, INC.
Stock Option (Right to Buy)
A - Award 200,000 200,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)